VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf2/HO-1 Signaling Pathway in Diabetic Nephropathy

被引:53
作者
Wang, Hui [1 ,2 ,3 ,4 ]
Yu, Xiaoyue [1 ,2 ,3 ,4 ]
Liu, Dongwei [1 ,2 ,3 ,4 ]
Qiao, Yingjin [5 ]
Huo, Jinling [1 ,2 ,3 ,4 ]
Pan, Shaokang [1 ,2 ,3 ,4 ]
Zhou, Lijuan [6 ]
Wang, Rui [1 ,2 ,3 ,4 ]
Feng, Qi [1 ,2 ,3 ,4 ]
Liu, Zhangsuo [1 ,2 ,3 ,4 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Res Inst Nephrol, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, Tradit Chinese Med Integrated Dept Nephrol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[3] Henan Prov Res Ctr Kidney Dis, Zhengzhou 450052, Peoples R China
[4] Key Lab Precis Diag & Treatment Chron Kidney Dis H, Zhengzhou 450052, Peoples R China
[5] Zhengzhou Univ, Blood Purificat Ctr, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[6] Zhengzhou Univ, Electron Microscopy Lab Renal Pathol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
diabetic nephropathy (DN); ferroptosis; Nrf2/HO-1 signaling pathway; renal tubular epithelial cell; vitamin D receptor (VDR); VITAMIN-D; KIDNEY; DEATH; INHIBITION; METABOLISM; IRON;
D O I
10.1002/advs.202305563
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Diabetic nephropathy (DN) is a serious microvascular complication of diabetes. Ferroptosis, a new form of cell death, plays a crucial role in the pathogenesis of DN. Renal tubular injury triggered by ferroptosis might be essential in this process. Numerous studies demonstrate that the vitamin D receptor (VDR) exerts beneficial effects by suppressing ferroptosis. However, the underlying mechanism has not been fully elucidated. Thus, they verified the nephroprotective effect of VDR activation and explored the mechanism by which VDR activation suppressed ferroptosis in db/db mice and high glucose-cultured proximal tubular epithelial cells (PTECs). Paricalcitol (PAR) is a VDR agonist that can mitigate kidney injury and prevent renal dysfunction. PAR treatment could inhibit ferroptosis of PTECs through decreasing iron content, increasing glutathione (GSH) levels, reducing malondialdehyde (MDA) generation, decreasing the expression of positive ferroptosis mediator transferrin receptor 1 (TFR-1), and enhancing the expression of negative ferroptosis mediators including ferritin heavy chain (FTH-1), glutathione peroxidase 4 (GPX4), and cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11). Mechanistically, VDR activation upregulated the NFE2-related factor 2/heme oxygenase-1 (Nrf2/HO-1) signaling pathway to suppress ferroptosis in PTECs. These findings suggested that VDR activation inhibited ferroptosis of PTECs in DN via modulating the Nrf2/HO-1 signaling pathway. VDR activation by paricalcitol (PAR) alleviates diabetic kidney injury by inhibiting renal tubular epithelial cell ferroptosis through regulating Nrf2/HO-1 signaling pathway. During this process, the activated VDR/Nrf2/HO-1 signaling pathway can significantly decrease the iron content and MDA generation, increase GSH level, reduce the expression of TFR-1, and enhance the expression of FTH-1, GPX4, and SLC7A11.image
引用
收藏
页数:14
相关论文
共 39 条
[1]   Diabetic Kidney Disease Challenges, Progress, and Possibilities [J].
Alicic, Radica Z. ;
Rooney, Michele T. ;
Tuttle, Katherine R. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (12) :2032-2045
[2]   1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling [J].
Chen, Lulu ;
Yang, Renlei ;
Qiao, Wanxin ;
Zhang, Wei ;
Chen, Jie ;
Mao, Li ;
Goltzman, David ;
Miao, Dengshun .
AGING CELL, 2019, 18 (03)
[3]   Vitamin D & its analogues in type 2 diabetic nephropathy: A systematic review [J].
Chokhandre M.K. ;
Mahmoud M.I. ;
Hakami T. ;
Jafer M. ;
Inamdar A.S. .
Journal of Diabetes & Metabolic Disorders, 14 (1)
[4]  
Clark J. Derrell, 1997, ILAR J, V38, P41
[5]   Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes [J].
Coughlan, Melinda T. ;
Tuong-Vi Nguyen ;
Penfold, Sally A. ;
Higgins, Gavin C. ;
Thallas-Bonke, Vicki ;
Tan, Sih Min ;
Van Bergen, Nicole J. ;
Sourris, Karly C. ;
Harcourt, Brooke E. ;
Thorburn, David R. ;
Trounce, Ian A. ;
Cooper, Mark E. ;
Forbes, Josephine M. .
CLINICAL SCIENCE, 2016, 130 (09) :711-720
[6]   Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors [J].
DeFronzo, Ralph A. ;
Reeves, W. Brian ;
Awad, Alaa S. .
NATURE REVIEWS NEPHROLOGY, 2021, 17 (05) :319-334
[7]   Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death [J].
Dixon, Scott J. ;
Lemberg, Kathryn M. ;
Lamprecht, Michael R. ;
Skouta, Rachid ;
Zaitsev, Eleina M. ;
Gleason, Caroline E. ;
Patel, Darpan N. ;
Bauer, Andras J. ;
Cantley, Alexandra M. ;
Yang, Wan Seok ;
Morrison, Barclay, III ;
Stockwell, Brent R. .
CELL, 2012, 149 (05) :1060-1072
[8]   NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis [J].
Dodson, Matthew ;
Castro-Portuguez, Raul ;
Zhang, Donna D. .
REDOX BIOLOGY, 2019, 23
[9]   FSP1 is a glutathione-independent ferroptosis suppressor [J].
Doll, Sebastian ;
Freitas, Florencio Porto ;
Shah, Ron ;
Aldrovandi, Maceler ;
da Silva, Milene Costa ;
Ingold, Irina ;
Grocin, Andrea Goya ;
da Silva, Thamara Nishida Xavier ;
Panzilius, Elena ;
Scheel, Christina H. ;
Mourao, Andre ;
Buday, Katalin ;
Sato, Mami ;
Wanninger, Jonas ;
Vignane, Thibaut ;
Mohana, Vaishnavi ;
Rehberg, Markus ;
Flatley, Andrew ;
Schepers, Aloys ;
Kurz, Andreas ;
White, Daniel ;
Sauer, Markus ;
Sattler, Michael ;
Tate, Edward William ;
Schmitz, Werner ;
Schulze, Almut ;
O'Donnell, Valerie ;
Proneth, Bettina ;
Popowicz, Grzegorz M. ;
Pratt, Derek A. ;
Angeli, Jose Pedro Friedmann ;
Conrad, Marcus .
NATURE, 2019, 575 (7784) :693-+
[10]   Renal iron overload in rats with diabetic nephropathy [J].
Dominguez, Jesus H. ;
Liu, Yunlong ;
Kelly, Katherine. J. .
PHYSIOLOGICAL REPORTS, 2015, 3 (12)